Foghorn Therapeutics (FHTX) Accumulated Depreciation & Amortization: 2020-2025
Historic Accumulated Depreciation & Amortization for Foghorn Therapeutics (FHTX) over the last 6 years, with Sep 2025 value amounting to $900,000.
- Foghorn Therapeutics' Accumulated Depreciation & Amortization rose 28.57% to $900,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 3.46%. This contributed to the annual value of $3.1 million for FY2024, which is 10.86% down from last year.
- Per Foghorn Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $900,000 for Q3 2025, which was down 0.00% from $900,000 recorded in Q2 2025.
- Foghorn Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $900,000 for Q3 2022, and its period low was $700,000 during Q3 2024.
- Its 3-year average for Accumulated Depreciation & Amortization is $834,727, with a median of $835,000 in 2024.
- As far as peak fluctuations go, Foghorn Therapeutics' Accumulated Depreciation & Amortization soared by 300.00% in 2021, and later fell by 22.22% in 2024.
- Over the past 5 years, Foghorn Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $810,000 in 2021, then rose by 1.36% to $821,000 in 2022, then increased by 9.62% to $900,000 in 2023, then dropped by 20.00% to $720,000 in 2024, then increased by 28.57% to $900,000 in 2025.
- Its Accumulated Depreciation & Amortization stands at $900,000 for Q3 2025, versus $900,000 for Q2 2025 and $827,000 for Q1 2025.